Neurology Consultant Advisory Board Member Anamaria Shanley, MSN, APRN-C, discusses the impact of the COVID-19 pandemic, social distancing, and the transition to telemedicine on the older adults she sees in...
Co-Chair Daniel Einhorn, MD, FACP, FACE, talks with fellow Co-Chair Edward Shahady, MD, FAAFP, ABCL about the early results of SGLT2 inhibitors and the cardiovascular benefits and cardiac outcomes.
Summit Keynote Speaker John E. Anderson, MD, The First Clinic, addressed clinicians in the audience on the impact cardiometabolic risk - diabetes, hypertension, dyslipidemia, and obesity - is having on the...
